货号:A119196
同义名:
两性霉素B
/ LNS-AmB; NSC 527017
Amphotericin B是一种多烯类抗真菌药,源自链霉菌,通过特异性结合真菌细胞膜甾醇成分(如麦角固醇)改变膜通透性,促使胞内钾离子及氨基酸外泄,最终导致真菌代谢紊乱和死亡。因细菌细胞膜缺乏甾醇而对细菌无抑制作用,Amphotericin B可与双抗一起使用,预防细胞受真菌和细菌污染。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Amphotericin B (AmB) is the most effective drug for treating many life-threatening fungal infections. TLR2 (Toll-like receptors) and CD14 are required for amphotericin B-dependent inflammatory stimulation of innate immune cells and that TLR4 may also provide stimulation of these cells[1]. AmB only kills unicellular Leishmania promastigotes (LPs) when aqueous pores permeable to small cations and anions are formed. At low concentrations (≤0.1 microM), AmB was found to be nonlethal against LPs but, above this concentration, leishmanias were rapidly killed[3]. Amphotericin B treatment of hamsters infected with scrapie strain 263K prolongs the incubation period of the disease [4]. |
| 体内研究 | To test antifungal activity in vivo, Amphotericin B (0.25-4 mg/kg) was administered as a single intraperitoneal injection to C. albicans K-1-infected ICR/Swiss mice. Only the highest single dose of Amphotericin B treatment significantly reduced the number of colonies compared to the number of colonies at the start of treatment [7]. |
| 体外研究 | Human normal colonic epithelial cells CCD 841 CoTr and human colorectal cancer cells HT-29 were treated with Amphotericin B (0.05-25 µg/mL) for 24 h. Cell viability was measured by Neutral Red method. Higher concentrations of Amphotericin B were toxic to CCD 841 CoTr and HT-29 cells with IC50 values of 8.7 µg/mL and 21.2 µg/mL, respectively[5]. Candida albicans were treated with Amphotericin B (100 µM) for 4-16 min and imaged using the FLIM technique.Amphotericin B preferentially binds to the cell wall and does not efficiently cross the barrier covering the cell membrane.Amphotericin B is able to pass through the cell wall barrier of young cells more readily in the emergence phase. Amphotericin B can more easily pass through the cell wall barrier of young cells at the emergence stage [6]. |
| Concentration | Treated Time | Description | References | |
| Mouse Embryonic Fibroblasts (MEFs) | 25 ng/ml | Used for culturing MEFs to study the effect of GPC1 on cell migration | Oncogene. 2012 May 17;31(20):2535-44. | |
| Human and mice immune cells | 250 ng/mL | Used for the culture of immune cells to maintain a sterile environment. | Cell Death Dis. 2019 Feb 8;10(2):113. | |
| Human and mice stromal cells | 250 ng/mL | Used for the culture of stromal cells to maintain a sterile environment. | Cell Death Dis. 2019 Feb 8;10(2):113. | |
| bone marrow-derived macrophages (BMM) | 5 μg/ml | 3 weeks | Used to inhibit fungal growth to assess the growth of Mycobacterium tuberculosis. | mBio. 2022 Oct 26;13(5):e0108622. |
| L. major promastigotes | 207 nM | 44 h | Determine the growth inhibitory activity of Amphotericin B against L. major promastigotes, EC50 was 207 nM | PLoS Negl Trop Dis. 2009 Nov 3;3(11):e540. |
| L. major axenic amastigote-like parasites | 380 nM | 144 h | Determine the growth inhibitory activity of Amphotericin B against L. major axenic amastigote-like parasites, EC50 was 380 nM | PLoS Negl Trop Dis. 2009 Nov 3;3(11):e540. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Wild-type mice | Oral | 0.2 mL of 0.1 mg/ml | Every 12 hours for three days | To deplete the gut microbiota in mice for studying its impact on pancreatic tumors | Cancer Res. 2020 Mar 1;80(5):1088-1101 |
| Mice | Chronic Social Defeat Stress model | Intraperitoneal injection | 1 mg/kg | Single injection | Amphotericin B liposomes reversed and prevented behavioral abnormalities in mice induced by chronic social defeat stress (CSDS) by activating the innate immune system. | Front Pharmacol. 2022 Jul 15;13:918177 |
| Mice | Antibiotic-induced gut microbiota depletion model | Gavage | 1 mg/kg | Every 12 hours for three days | To study the effect of Amphotericin B on sleep promotion in mice through antibiotic-induced gut microbiota depletion. The results showed that antibiotic treatment blocked Amphotericin B-induced alterations in sleep behavior and increases in 5-HT levels. | Sci Rep. 2021 Jul 1;11(1):13660 |
| Mice | Pasteurella multocida type‐A (PmCQ2) infection model | Drinking water | 0.1 mg/mL | Continued for 3 weeks | To investigate the impact of intestinal mycobiota dysbiosis on lung inflammation, the results showed that Amphotericin B treatment increased mortality and lung bacterial loads, and enhanced the production of inflammatory cytokines in the serum and lung. | Imeta. 2024 Sep 14;3(5):e241 |
| Balb/c mice | L. major infection model | Subcutaneous injection | 12.5 mg/kg | Once daily for 21 days | Evaluate the efficacy of Amphotericin B in the L. major infected mouse model, results showed Amphotericin B effectively reduced footpad swelling | PLoS Negl Trop Dis. 2009 Nov 3;3(11):e540. |
| Mice | C57BL/6J mice | Oral | 0.2 g/L | Water changes every 3 days for 2 weeks | Used for antibiotic pre-treatment to eliminate the regulatory activity of the IH microbiota | Cell Host Microbe. 2022 Sep 14;30(9):1295-1310.e8 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00163111 | Candidiasis | Phase 3 | Completed | - | - |
| NCT00370825 | Visceral Leishmaniasis | Phase 2 | Completed | - | India ... 展开 >> Kala-azar Medical Research Center Muzaffarpur, Bihar, India, 842001 收起 << |
| NCT00002742 | Chronic Myeloproliferative Dis... 展开 >>orders Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 3 | Completed | - | - |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.08mL 0.22mL 0.11mL |
5.41mL 1.08mL 0.54mL |
10.82mL 2.16mL 1.08mL |
|
| CAS号 | 1397-89-3 |
| 分子式 | C47H73NO17 |
| 分子量 | 924.08 |
| SMILES Code | C[C@H]([C@@H](O)[C@@H](C)[C@H](C)OC1=O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@]2([H])O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@]3([H])[C@H](C(O)=O)[C@@H](O)C[C@](C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C1)(O)O3 |
| MDL No. | MFCD00877763 |
| 别名 | 两性霉素B ;LNS-AmB; NSC 527017; Fungizone |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 50 mg/mL(54.11 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1